Intensity Therapeutics, Inc.

INTS · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$2,590$8,556$1,312$4,539
Short-Term Investments$0$6,220$0$0
Receivables$0$0$62$51
Inventory$0$0$0$0
Other Curr. Assets$773$688$77$140
Total Curr. Assets$3,363$15,464$1,451$4,730
Property Plant & Equip (Net)$122$147$139$318
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,298$1,684$167$168
Total NC Assets$1,420$1,831$306$486
Other Assets$0$0$0$0
Total Assets$4,783$17,295$1,757$5,216
Liabilities
Payables$1,219$3,048$603$173
Short-Term Debt$28$20$4,492$2,199
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$508$891$1,724$1,349
Total Curr. Liab.$1,755$3,959$6,819$3,721
LT Debt$110$138$0$144
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$36$10,036$10,036
Total NC Liab.$110$174$10,036$10,180
Other Liabilities$0$0$0$0
Cap. Leases$138$158$143$326
Total Liabilities$1,865$4,133$16,855$13,900
Equity
Pref Stock$0$17,295$0$0
Common Stock$2$1$0$0
Retained Earnings-$66,783-$50,515-$38,653-$31,071
AOCI$0-$17,295$0$0
Other Equity$69,699$63,676$23,555$22,386
Total Equity$2,918$13,162-$15,098-$8,684
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$4,783$17,295$1,757$5,216
Net Debt-$2,452-$8,398$3,180-$2,197
Intensity Therapeutics, Inc. (INTS) Financial Statements & Key Stats | AlphaPilot